Business
Harmony Biosciences Announces Funding for Unique Community Initiatives Through its Patients and Progress at the Heart Awards Programs
Awards accelerate nonprofit organizations' commitments to addressing unmet needs within the sleep and rare neurological disease communities PLYMOUTH MEETING,
About this update from Harmony Biosciences Holdings, Inc.
[{"type":"text","content":"Awards accelerate nonprofit organizations' commitments to addressing unmet needs within the sleep and rare neurological disease communities\n\n\nPLYMOUTH MEETING, Pa., July 25, 2023 /PRNewswire/ -- Harmony Biosciences selected the latest round of nonprofit organizations for its Patients at the Heart and Progress at the Heart awards, which provide funding toward interdisciplinary community initiatives that address complex challenges facing people living with sleep disorders and rare neurological diseases.\n\n \n \n \n \n \n \n\n \nHarmony Biosciences Holdings, Inc. (\"Harmony\") (Nasdaq: HRMY), is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases.\nOver the last four years, Patients at the Heart has provided funding for 22 initiatives working to address the holistic needs of people and their families affected by sleep disorders and rare neurological diseases.\n\"Women living with narcolepsy encounter distinct challenges that persist throughout their lives, leading to additional health burdens during pregnancy, lactation, and caregiving,\" said Kathryn Schubert, President and CEO of the Society for Women's Health Research, a Patients at the Heart award recipient. \"With the support of this funding, we can advance our educational program 'The Impact of Narcolepsy on Women's Health Across the Lifespan.' This new work will focus on caregiving aspects, aimed at helping combat stigma, promote timely diagnosis in children, and empower mothers to advocate for their children within school systems by providing educational narcolepsy resources and related support.\"\nProgress at the Heart provides funding support for novel initiatives addressing disparities, injustices, and inequities in the rare neurological disease and sleep disorder communities. Since its inception two years ago, it has provided funding for 13 initiatives.\n\"Receiving a Progress at the Heart award enables us to further address social determinants of health predominantly affecting Latino and Hispanic families at the US-Mexico border,\" expressed Michael Grandner, PhD, Director of the Behavioral Sleep Medicine Clinic at the University of Arizona. \"Through strategic local partnerships, health literacy education, and culturally competent care sessions with sleep medicine psychologists, our...